Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
4.330
-0.100 (-2.26%)
Nov 21, 2024, 4:00 PM EST - Market closed
Acelyrin Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -264.41 | -381.64 | -64.77 | -41.84 |
| Depreciation & Amortization | 0.33 | 0.12 | - | - |
| Asset Writedown & Restructuring Costs | - | 133.06 | - | 25 |
| Loss (Gain) From Sale of Investments | -20.04 | -10.5 | -0.25 | - |
| Stock-Based Compensation | 53.76 | 47.32 | 4.05 | 0.23 |
| Other Operating Activities | 0.37 | -10.14 | -0.49 | - |
| Change in Accounts Payable | -1.15 | 34.44 | 3.78 | 1.12 |
| Change in Other Net Operating Assets | -19.19 | 17.64 | -3.84 | 10.51 |
| Operating Cash Flow | -255.97 | -169.71 | -61.52 | -4.98 |
| Capital Expenditures | -1.26 | -2.29 | - | - |
| Cash Acquisitions | - | 10.01 | -0.08 | - |
| Sale (Purchase) of Intangibles | - | -10 | - | -25 |
| Investment in Securities | 79.25 | -445.46 | -47.79 | - |
| Investing Cash Flow | 84.98 | -447.74 | -47.87 | -25 |
| Issuance of Common Stock | 6.12 | 576.76 | - | 0.02 |
| Repurchase of Common Stock | - | -8.33 | - | - |
| Other Financing Activities | - | - | 10.29 | - |
| Financing Cash Flow | 6.12 | 568.44 | 274.26 | 124.72 |
| Net Cash Flow | -164.87 | -49.01 | 164.87 | 94.74 |
| Free Cash Flow | -257.23 | -172 | -61.52 | -4.98 |
| Free Cash Flow Per Share | -2.61 | -2.45 | -39.50 | -7.24 |
| Levered Free Cash Flow | -191.74 | -89.95 | -36.41 | - |
| Unlevered Free Cash Flow | -191.74 | -89.95 | -36.41 | - |
| Change in Net Working Capital | 11.22 | -55.17 | -2.78 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.